{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:51:36Z","timestamp":1790369496206,"version":"4.1.0"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["Rede Mineira de Nanomedicina Teran\u00f3stica, grant number FAPEMIG RED-00079-22"],"award-info":[{"award-number":["Rede Mineira de Nanomedicina Teran\u00f3stica, grant number FAPEMIG RED-00079-22"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"DOI":"10.1186\/s12913-026-14030-2","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T06:45:10Z","timestamp":1768200310000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Nanomedicine as an opportunity for equity achievements through cost-reduction in public healthcare for head and neck cancer treatment in Brazil"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2594-4617","authenticated-orcid":false,"given":"Lidia Maria","family":"de Andrade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4935-6070","authenticated-orcid":false,"given":"Luiz Orlando","family":"Ladeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"14030_CR1","doi-asserted-by":"publisher","unstructured":"Ebrahimi E, Sangphukieo A, Park HA, Gaborieau A, Ferreiro-Iglesias A, Diergaarde B, et al. Cross-ancestral GWAS identifies 29 variants across head and neck cancer subsites. Nat Commun. 2025;16:18. https:\/\/doi.org\/10.1038\/s41467-025-63842-z","DOI":"10.1038\/s41467-025-63842-z"},{"key":"14030_CR2","doi-asserted-by":"publisher","unstructured":"Shah JP, Johnson NW. Oral and oropharyngeal cancer. 2nd ed. London: Taylor & Francis; 2018. https:\/\/doi.org\/10.1201\/9781351138543","DOI":"10.1201\/9781351138543"},{"key":"14030_CR3","doi-asserted-by":"publisher","unstructured":"Wang CC, Yeh SA, Chen WH, Li HJ, Yang CC, Huang TJ, et al. Evaluating cetuximab regimens in head and neck cancer: insights from a retrospective cohort study. Cancers (Basel). 2025;17. https:\/\/doi.org\/10.3390\/cancers17020210.","DOI":"10.3390\/cancers17020210"},{"key":"14030_CR4","doi-asserted-by":"crossref","unstructured":"Santos MDO, Lima FC da, de Martins S, Oliveira LFL, Almeida JFP, de Cancela LM. MDC. Estimated Cancer Incidence in Brazil, 2023\u20132025. Rev Bras Cancerol. 2023;69:2023\u20135.","DOI":"10.32635\/2176-9745.RBC.2023v69n1.3700"},{"key":"14030_CR5","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1590\/S0034-72992006000500019","volume":"72","author":"B Correia Jham","year":"2006","unstructured":"Correia Jham B, Regina da Silva Freire A. Oral complications of radiotherapy in the head and neck summary. Braz J Otorhinolaryngol. 2006;72:704\u20138. https:\/\/doi.org\/10.1590\/S0034-72992006000500019.","journal-title":"Braz J Otorhinolaryngol"},{"key":"14030_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-019-6190-3","volume":"19","author":"MJS Da Silva","year":"2019","unstructured":"Da Silva MJS, O\u2019Dwyer G, Osorio-De-Castro CGS. Cancer care in brazil: structure and geographical distribution. BMC Cancer. 2019;19:1\u201311. https:\/\/doi.org\/10.1186\/s12885-019-6190-3.","journal-title":"BMC Cancer"},{"key":"14030_CR7","doi-asserted-by":"publisher","first-page":"100986","DOI":"10.1016\/j.lana.2024.100986","volume":"42","author":"F Nascimento de Carvalho","year":"2025","unstructured":"Nascimento de Carvalho F, de Camargo Cancela M, Mesentier da Costa L, Leite Martins LF, Dias FL, Bezerra de Souza DL, et al. Disparities in stage at diagnosis of head and neck tumours in brazil: a comprehensive analysis of hospital-based cancer registries. Lancet Reg Heal - Am. 2025;42:100986. https:\/\/doi.org\/10.1016\/j.lana.2024.100986.","journal-title":"Lancet Reg Heal - Am"},{"key":"14030_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-025-04285-w","volume":"15","author":"C Crowley","year":"2025","unstructured":"Crowley C, Harner B, Stuck AR, Kent T. New healthcare payment models: risk scores aren\u2019t enough to guide resource allocation. Sci Rep. 2025;15:1\u20139. https:\/\/doi.org\/10.1038\/s41598-025-04285-w.","journal-title":"Sci Rep"},{"key":"14030_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12913-021-06807-4","volume":"21","author":"M Malmmose","year":"2021","unstructured":"Malmmose M, Lydersen JP. From centralized DRG costing to decentralized TDABC-assessing the feasibility of hospital cost accounting for decision-making in Denmark. BMC Health Serv Res. 2021;21:1\u201315. https:\/\/doi.org\/10.1186\/s12913-021-06807-4.","journal-title":"BMC Health Serv Res"},{"key":"14030_CR10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.vhri.2020.05.008","volume":"23","author":"AP Lana","year":"2020","unstructured":"Lana AP, Perelman J, Gurgel Andrade EI, Ac\u00farcio F, Guerra AA, Cherchiglia ML. Cost analysis of cancer in brazil: A Population-Based study of patients treated by public health System, from 2001\u20132015. Value Heal Reg Issues. 2020;23:137\u201347. https:\/\/doi.org\/10.1016\/j.vhri.2020.05.008.","journal-title":"Value Heal Reg Issues"},{"key":"14030_CR11","unstructured":"Minist\u00e9rio do Desenvolvimento. Ind\u00fastria C e S. Nova ind\u00fastria Brasil \u2013 forte, Transformadora e sustent\u00e1vel: Plano de A\u00e7\u00e3o Ara a neoindustrializa\u00e7\u00e3o 2024\u20132026. Brasilia; 2024."},{"key":"14030_CR12","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.3390\/nano12122053","volume":"12","author":"TRS Malagrino","year":"2022","unstructured":"Malagrino TRS, Godoy AP, Barbosa JM, Lima AGT, Sousa NCO, Pedrotti JJ, et al. Multifunctional hybrid MoS2-PEGylated\/Au nanostructures with potential theranostic applications in biomedicine. Nanomaterials. 2022;12:2053. https:\/\/doi.org\/10.3390\/nano12122053.","journal-title":"Nanomaterials"},{"key":"14030_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2217\/fvl-2015-0010","volume":"11","author":"AF Versiani","year":"2016","unstructured":"Versiani AF, Andrade LM, Martins EM, Scalzo S, Geraldo JM, Chaves CR, et al. Gold nanoparticles and their applications in biomedicine. Future Virol. 2016;11:1\u201317. https:\/\/doi.org\/10.2217\/fvl-2015-0010.","journal-title":"Future Virol"},{"key":"14030_CR14","doi-asserted-by":"publisher","first-page":"e42738","DOI":"10.1016\/j.heliyon.2025.e42738","volume":"11","author":"A Badir","year":"2025","unstructured":"Badir A, Refki S, Sekkat Z. Utilizing gold nanoparticles in plasmonic photothermal therapy for cancer treatment. Heliyon. 2025;11:e42738. https:\/\/doi.org\/10.1016\/j.heliyon.2025.e42738.","journal-title":"Heliyon"},{"key":"14030_CR15","doi-asserted-by":"publisher","unstructured":"Sun L, Liu H, Ye Y, Lei Y, Islam R, Tan S, et al. Smart nanoparticles for cancer therapy. Signal Transduct Target Ther. 2023;8. https:\/\/doi.org\/10.1038\/s41392-023-01642-x.","DOI":"10.1038\/s41392-023-01642-x"},{"key":"14030_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-68357-9","volume":"10","author":"AF Versiani","year":"2020","unstructured":"Versiani AF, Martins EMN, Andrade LM, Cox L, Pereira GC, Barbosa-Stancioli EF, et al. Nanosensors based on LSPR are able to serologically differentiate dengue from Zika infections. Sci Rep. 2020;10:1\u201317. https:\/\/doi.org\/10.1038\/s41598-020-68357-9.","journal-title":"Sci Rep"},{"key":"14030_CR17","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s44328-025-00029-y","volume":"2","author":"AF Versiani","year":"2025","unstructured":"Versiani AF, Andrade LM, Moraes TFS, Martins EMN, Bagno FF, Andrade LAF, et al. Serologic LSPR-nanosensor against SARS-COV-2 antibodies and related variants outperforms ELISA in sensitivity. Npj Biosensing. 2025;2:12. https:\/\/doi.org\/10.1038\/s44328-025-00029-y.","journal-title":"Npj Biosensing"},{"key":"14030_CR18","doi-asserted-by":"publisher","first-page":"6813","DOI":"10.1021\/acs.analchem.4c04934","volume":"97","author":"FC Santana","year":"2025","unstructured":"Santana FC, Mendes A, Moraes TFS, Andrade LM, Versiani AF, Martins MN, et al. Advanced computational techniques for plasmonic metasurfaces in the detection of neglected infectious diseases. Anal Chem. 2025;97:6813\u201325. https:\/\/doi.org\/10.1021\/acs.analchem.4c04934.","journal-title":"Anal Chem"},{"key":"14030_CR19","doi-asserted-by":"publisher","unstructured":"Andrade LM, Cox L, Versiani AF, Da Fonseca FG. A growing world of small things: A brief review on the nanostructured vaccines. Future Virol. 2017;12. https:\/\/doi.org\/10.2217\/fvl-2017-0086.","DOI":"10.2217\/fvl-2017-0086"},{"key":"14030_CR20","doi-asserted-by":"publisher","unstructured":"Huang H, Liu R, Yang J, Dai J, Fan S, Pi J, et al. Gold nanoparticles: construction for drug delivery and application in cancer immunotherapy. Pharmaceutics. 2023;15. https:\/\/doi.org\/10.3390\/pharmaceutics15071868.","DOI":"10.3390\/pharmaceutics15071868"},{"key":"14030_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fbioe.2021.647905","volume":"9","author":"Q Gao","year":"2021","unstructured":"Gao Q, Zhang J, Gao J, Zhang Z, Zhu H, Wang D. Gold nanoparticles in cancer theranostics. Front Bioeng Biotechnol. 2021;9:1\u201320. https:\/\/doi.org\/10.3389\/fbioe.2021.647905.","journal-title":"Front Bioeng Biotechnol"},{"key":"14030_CR22","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1039\/d0tb02309d","volume":"9","author":"DS Reis","year":"2021","unstructured":"Reis DS, de Oliveira VL, Silva ML, Paniago RM, Ladeira LO, Andrade LM. Gold nanoparticles enhance fluorescence signals by flow cytometry at low antibody concentrations. J Mater Chem B. 2021;9:1414\u201323. https:\/\/doi.org\/10.1039\/d0tb02309d.","journal-title":"J Mater Chem B"},{"key":"14030_CR23","doi-asserted-by":"publisher","first-page":"9407","DOI":"10.2147\/IJN.S272902","volume":"15","author":"Y Chen","year":"2020","unstructured":"Chen Y, Yang J, Fu S, Wu J. Gold nanoparticles as radiosensitizers in cancer radiotherapy. Int J Nanomed. 2020;15:9407\u201330. https:\/\/doi.org\/10.2147\/IJN.S272902.","journal-title":"Int J Nanomed"},{"key":"14030_CR24","doi-asserted-by":"publisher","first-page":"18590","DOI":"10.1073\/pnas.1906929116","volume":"116","author":"AR Rastinehad","year":"2019","unstructured":"Rastinehad AR, Anastos H, Wajswol E, Winoker JS, Sfakianos JP, Doppalapudi SK, et al. Gold nanoshell-localized photothermal ablation of prostate tumors in a clinical pilot device study. Proc Natl Acad Sci U S A. 2019;116:18590\u20136. https:\/\/doi.org\/10.1073\/pnas.1906929116.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"14030_CR25","doi-asserted-by":"publisher","unstructured":"Viegas C, Pereira DSM, Fonte P. Insights into nanomedicine for head and neck cancer diagnosis and treatment. Materials. 2022;15. https:\/\/doi.org\/10.3390\/ma15062086.","DOI":"10.3390\/ma15062086"},{"key":"14030_CR26","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1080\/14686996.2020.1855064","volume":"21","author":"Y Liu","year":"2020","unstructured":"Liu Y, Ma Y, Peng X, Wang L, Li H, Cheng W, et al. Cetuximab-conjugated perfluorohexane\/gold nanoparticles for low intensity focused ultrasound diagnosis ablation of thyroid cancer treatment. Sci Technol Adv Mater. 2020;21:856\u201366. https:\/\/doi.org\/10.1080\/14686996.2020.1855064.","journal-title":"Sci Technol Adv Mater"},{"key":"14030_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnano.2024.1479993","volume":"6","author":"RV Kumarasamy","year":"2024","unstructured":"Kumarasamy RV, Natarajan PM, Umapathy VR, Roy JR, Mironescu M, Palanisamy CP. Clinical applications and therapeutic potentials of advanced nanoparticles: a comprehensive review on completed human clinical trials. Front Nanotechnol. 2024;6:1\u201325. https:\/\/doi.org\/10.3389\/fnano.2024.1479993.","journal-title":"Front Nanotechnol"},{"key":"14030_CR28","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s40005-022-00607-6","volume":"53","author":"RK Thapa","year":"2023","unstructured":"Thapa RK, Kim JO. Nanomedicine-based commercial formulations: current developments and future prospects. J Pharm Invest. 2023;53:19\u201333. https:\/\/doi.org\/10.1007\/s40005-022-00607-6.","journal-title":"J Pharm Invest"},{"key":"14030_CR29","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1126\/sciadv.adx1576","volume":"11","author":"H Forgham","year":"2025","unstructured":"Forgham H, Chang Y, Wang Y, Zhu J, Liu L, Biggs H, et al. The evolution of nanomedicine: the rise of next-generation nanomaterials in cancer nanomedicine. Sci Adv. 2025;11:1576. https:\/\/doi.org\/10.1126\/sciadv.adx1576.","journal-title":"Sci Adv"},{"key":"14030_CR30","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.2147\/DDDT.S470210","volume":"18","author":"H Zhang","year":"2024","unstructured":"Zhang H, Li S, Ma X. Transforming healthcare with nanomedicine: A SWOT analysis of drug delivery innovation. Drug Des Devel Ther. 2024;18:3499\u2013521. https:\/\/doi.org\/10.2147\/DDDT.S470210.","journal-title":"Drug Des Devel Ther"},{"key":"14030_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnano.2024.1348308","volume":"6","author":"F Ulucan-Karnak","year":"2024","unstructured":"Ulucan-Karnak F, Kuru C\u0130, Akg\u00f6l S. Commercial roadmap of nanobiosensor development. Front Nanotechnol. 2024;6:1\u20137. https:\/\/doi.org\/10.3389\/fnano.2024.1348308.","journal-title":"Front Nanotechnol"},{"key":"14030_CR32","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1146\/annurev-chembioeng-060816-101522","volume":"8","author":"SH Behrens","year":"2017","unstructured":"Behrens SH, Breedveld V, Mujica M, Filler MA. Process principles for large-scale Nanomanufacturing. Annu Rev Chem Biomol Eng. 2017;8:201\u201326. https:\/\/doi.org\/10.1146\/annurev-chembioeng-060816-101522.","journal-title":"Annu Rev Chem Biomol Eng"},{"key":"14030_CR33","doi-asserted-by":"publisher","unstructured":"Cooper K. Scalable nanomanufacturing-a review. Micromachines. 2017;8. https:\/\/doi.org\/10.3390\/mi8010020.","DOI":"10.3390\/mi8010020"},{"key":"14030_CR34","doi-asserted-by":"publisher","first-page":"2","DOI":"10.22533\/at.ed.3173302314091","volume":"3","author":"ML Silva","year":"2023","unstructured":"Silva ML, Nieto S, Andrade LM, Andrade MJ, Pedrosa AMC. Innovation hubs: leveraging nanotechnology LATAM market with a sustainable and collaborative mindset. J Eng Res. 2023;3:2\u20134. https:\/\/doi.org\/10.22533\/at.ed.3173302314091.","journal-title":"J Eng Res"},{"key":"14030_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/461687","volume":"2014","author":"N Feofanova","year":"2014","unstructured":"Feofanova N, Geraldo JM, Andrade LM, De. Radiation oncology in vitro: trends to improve radiotherapy through molecular targets. Biomed Res Int. 2014;2014:1\u201313. https:\/\/doi.org\/10.1155\/2014\/461687.","journal-title":"Biomed Res Int"},{"key":"14030_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers16020412","volume":"16","author":"N Saoudi Gonz\u00e1lez","year":"2024","unstructured":"Saoudi Gonz\u00e1lez N, Ros J, Baraibar I, Salv\u00e0 F, Rodr\u00edguez-Castells M, Alcaraz A, et al. Cetuximab as a key partner in personalized targeted therapy for metastatic colorectal cancer. Cancers (Basel). 2024;16:1\u201318. https:\/\/doi.org\/10.3390\/cancers16020412.","journal-title":"Cancers (Basel)"},{"key":"14030_CR37","doi-asserted-by":"publisher","unstructured":"El Hallal R, Lyu N, Wang Y. Effect of cetuximab-conjugated gold nanoparticles on the cytotoxicity and phenotypic evolution of colorectal cancer cells. Molecules. 2021;26. https:\/\/doi.org\/10.3390\/molecules26030567.","DOI":"10.3390\/molecules26030567"},{"key":"14030_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13012-024-01389-1","volume":"19","author":"N Freitas de Mello","year":"2024","unstructured":"Freitas de Mello N, Nascimento Silva S, Gomes DF, da Motta Girardi J, Barreto JOM. Models and frameworks for assessing the implementation of clinical practice guidelines: a systematic review. Implement Sci. 2024;19:1\u201315. https:\/\/doi.org\/10.1186\/s13012-024-01389-1.","journal-title":"Implement Sci"},{"key":"14030_CR39","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1002\/cphc.201601139","volume":"18","author":"S Jendrzej","year":"2017","unstructured":"Jendrzej S, G\u00f6kce B, Epple M, Barcikowski S. How size determines the value of gold: economic aspects of wet chemical and Laser-Based metal colloid synthesis. ChemPhysChem. 2017;18:1012\u20139. https:\/\/doi.org\/10.1002\/cphc.201601139.","journal-title":"ChemPhysChem"},{"key":"14030_CR40","doi-asserted-by":"publisher","unstructured":"Andrade LM, Costa GMJ. Insights into gold nanoparticles possibilities for diagnosis and treatment of the head and neck upper aerodigestive tract cancers. Cancers (Basel). 2023;15. https:\/\/doi.org\/10.3390\/cancers15072080.","DOI":"10.3390\/cancers15072080"},{"key":"14030_CR41","doi-asserted-by":"publisher","first-page":"102935","DOI":"10.1016\/j.canep.2025.102935","volume":"99","author":"AR da Cunha","year":"2025","unstructured":"da Cunha AR, Rumgay H, Vignat J, Laversanne M, Colombet M, Curado MP, et al. Global burden and international trends of laryngeal cancer incidence: A population-based study of recorded data and National estimates. Cancer Epidemiol. 2025;99:102935. https:\/\/doi.org\/10.1016\/j.canep.2025.102935.","journal-title":"Cancer Epidemiol"},{"key":"14030_CR42","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"key":"14030_CR43","unstructured":"Instituto Nacional de C\u00e2ncer. Jos\u00e9 Alencar Gomes da Silva (INCA). Estimativa 2023: incid\u00eancia de c\u00e2ncer no Brasil. 2022."},{"key":"14030_CR44","first-page":"213700","volume":"69","author":"M Santos","year":"2023","unstructured":"Santos M, de O, Lima FCdaS, Martins LFL, Oliveira JFP, de Almeida LM. Cancela M de C. Estimated cancer incidence in Brazil, 2023\u20132025. Brazilian J Cancerol. 2023;69:213700.","journal-title":"Brazilian J Cancerol"},{"key":"14030_CR45","doi-asserted-by":"publisher","unstructured":"Botha CR, Vermund SH. Estimating non-communicable disease treatment costs using probability-based cost Estimation. Glob Health Action. 2022;15. https:\/\/doi.org\/10.1080\/16549716.2021.2008627.","DOI":"10.1080\/16549716.2021.2008627"},{"key":"14030_CR46","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jval.2013.10.004","volume":"17","author":"D Coughlan","year":"2014","unstructured":"Coughlan D, Yeh ST, O\u2019Neill C, Frick KD. Evaluating direct medical expenditures Estimation methods of adults using the medical expenditure panel survey: an example focusing on head and neck cancer. Value Heal. 2014;17:90\u20137. https:\/\/doi.org\/10.1016\/j.jval.2013.10.004.","journal-title":"Value Heal"},{"key":"14030_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cnr2.1528","volume":"5","author":"MN Khan","year":"2022","unstructured":"Khan MN, Hueniken K, Manojlovic-Kolarski M, Eng L, Mirshams M, Khan K, et al. Out-of-pocket costs associated with head and neck cancer treatment. Cancer Rep. 2022;5:1\u201310. https:\/\/doi.org\/10.1002\/cnr2.1528.","journal-title":"Cancer Rep"},{"issue":"2 February","key":"14030_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0246475","volume":"16","author":"V Milani","year":"2021","unstructured":"Milani V, de Sene Am\u00e2ncio Zara AL, da Silva EN, Cardoso LB, Curado MP, Ribeiro-Rotta RF. Direct healthcare costs of lip, oral cavity and oropharyngeal cancer in Brazil. PLoS ONE. 2021;16(2 February):1\u201311. https:\/\/doi.org\/10.1371\/journal.pone.0246475.","journal-title":"PLoS ONE"},{"key":"14030_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnano.2024.1496230","volume":"6","author":"SG Guti\u00e9rrez-Cruz","year":"2024","unstructured":"Guti\u00e9rrez-Cruz SG, Mu\u00f1oz-Diosdado A, Guti\u00e9rrez-Calleja RA, Rodr\u00edguez-Cort\u00e9s O, Ortiz-Reyez AE, Flores-Mej\u00eda R. Influence of physicochemical factors on the interaction of metallic nanoparticles with immune system cells. Front Nanotechnol. 2024;6:1\u201325. https:\/\/doi.org\/10.3389\/fnano.2024.1496230.","journal-title":"Front Nanotechnol"},{"key":"14030_CR50","doi-asserted-by":"publisher","first-page":"4103","DOI":"10.2147\/IJN.S443168","volume":"19","author":"K Jakic","year":"2024","unstructured":"Jakic K, Selc M, Razga F, Nemethova V, Mazancova P, Havel F, et al. Long-Term Accumulation, biological effects and toxicity of BSA-Coated gold nanoparticles in the mouse Liver, Spleen, and kidneys. Int J Nanomed. 2024;19:4103\u201320. https:\/\/doi.org\/10.2147\/IJN.S443168.","journal-title":"Int J Nanomed"},{"key":"14030_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-022-10251-7","volume":"12","author":"FS Aljohani","year":"2022","unstructured":"Aljohani FS, Hamed MT, Bakr BA, Shahin YH, Abu-Serie MM, Awaad AK, et al. In vivo bio-distribution and acute toxicity evaluation of Greenly synthesized ultra-small gold nanoparticles with different biological activities. Sci Rep. 2022;12:1\u201320. https:\/\/doi.org\/10.1038\/s41598-022-10251-7.","journal-title":"Sci Rep"},{"key":"14030_CR52","doi-asserted-by":"publisher","first-page":"100469","DOI":"10.1016\/j.impact.2023.100469","volume":"31","author":"H Chen","year":"2023","unstructured":"Chen H, Zhou S, Chen W, Zhu M, Yu H, Zheng L, et al. PEG-GNPs aggravate MCD-induced steatohepatitic injury and liver fibrosis in mice through excessive lipid accumulation-mediated hepatic inflammatory damage. NanoImpact. 2023;31:100469. https:\/\/doi.org\/10.1016\/j.impact.2023.100469.","journal-title":"NanoImpact"},{"key":"14030_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnano.2025.1512622","volume":"7","author":"E Alexander","year":"2025","unstructured":"Alexander E, Leong KW. Toxicity and biodistribution comparison of functionalized nanodiamonds, quantum Dot nanocarbons and gold nanoparticles. Front Nanotechnol. 2025;7:1\u201318. https:\/\/doi.org\/10.3389\/fnano.2025.1512622.","journal-title":"Front Nanotechnol"},{"key":"14030_CR54","doi-asserted-by":"publisher","unstructured":"Sato T, Kakei Y, Hasegawa T, Kashin M, Teraoka S, Yamaguchi A, et al. Gold nanoparticles enhance the tumor Growth-Suppressing effects of cetuximab and radiotherapy in head and neck cancer in vitro and in vivo. Cancers (Basel). 2023;15. https:\/\/doi.org\/10.3390\/cancers15235697.","DOI":"10.3390\/cancers15235697"},{"key":"14030_CR55","doi-asserted-by":"publisher","unstructured":"Al-Khedhairy AA, Wahab R. Size-Dependent cytotoxic and molecular study of the use of gold nanoparticles against liver cancer cells. Appl Sci. 2022;12. https:\/\/doi.org\/10.3390\/app12020901.","DOI":"10.3390\/app12020901"},{"key":"14030_CR56","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1177\/1091581812465969","volume":"31","author":"SC Gad","year":"2012","unstructured":"Gad SC, Sharp KL, Montgomery C, Payne JD, Goodrich GP. Evaluation of the toxicity of intravenous delivery of auroshell particles (Gold-Silica Nanoshells). Int J Toxicol. 2012;31:584\u201394. https:\/\/doi.org\/10.1177\/1091581812465969.","journal-title":"Int J Toxicol"},{"key":"14030_CR57","doi-asserted-by":"publisher","unstructured":"Kanhai KMS, Zuiker R, Houghton W, Kramer WG, et al. A first-in-human study in healthy subjects of the safety and pharmacokinetics of CNM-Au8, a suspension of catalytically active gold nanocrystals with remyelinating and neuroprotective properties. medRxiv. 2023:1\u201327. https:\/\/doi.org\/10.1101\/2023.05.11.23289871","DOI":"10.1101\/2023.05.11.23289871"},{"key":"14030_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nano11071702","volume":"11","author":"K Kozics","year":"2021","unstructured":"Kozics K, Sramkova M, Kopecka K, Begerova P, Manova A, Krivosikova Z, et al. Pharmacokinetics, biodistribution, and biosafety of pegylated gold nanoparticles in vivo. Nanomaterials. 2021;11:1\u201317. https:\/\/doi.org\/10.3390\/nano11071702.","journal-title":"Nanomaterials"},{"key":"14030_CR59","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1007\/s13346-022-01232-4","volume":"13","author":"R Zhang","year":"2023","unstructured":"Zhang R, Kiessling F, Lammers T, Pallares RM. Clinical translation of gold nanoparticles. Drug Deliv Transl Res. 2023;13:378\u201385. https:\/\/doi.org\/10.1007\/s13346-022-01232-4.","journal-title":"Drug Deliv Transl Res"},{"key":"14030_CR60","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2147\/IJN.S219042","volume":"15","author":"M Khoobchandani","year":"2020","unstructured":"Khoobchandani M, Katti KK, Karikachery AR, Thipe VC, Srisrimal D, Mohandoss DKD, et al. New approaches in breast cancer therapy through green nanotechnology and nano-ayurvedic medicine \u2013 pre-clinical and pilot human clinical investigations. Int J Nanomed. 2020;15:181\u201397. https:\/\/doi.org\/10.2147\/IJN.S219042.","journal-title":"Int J Nanomed"},{"key":"14030_CR61","doi-asserted-by":"publisher","first-page":"102598","DOI":"10.1016\/j.nano.2022.102598","volume":"46","author":"AF Farag","year":"2022","unstructured":"Farag AF, Hassabou NF. CD24-gold nanocomposite as promising and sensitive biomarker for cancer stem cells in salivary gland tumors. Nanomed Nanatechnol Biol Med. 2022;46:102598. https:\/\/doi.org\/10.1016\/j.nano.2022.102598.","journal-title":"Nanomed Nanatechnol Biol Med"},{"key":"14030_CR62","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1515\/tjb-2023-0144","volume":"48","author":"F Ulucan-Karnak","year":"2023","unstructured":"Ulucan-Karnak F, Kuru CI, Sa\u01e7in FG. Critical evaluation of publications and patents in nanobiotechnology-based research in the last decade. Turkish J Biochem. 2023;48:606\u201319. https:\/\/doi.org\/10.1515\/tjb-2023-0144.","journal-title":"Turkish J Biochem"},{"key":"14030_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nano14221805","volume":"14","author":"H Duman","year":"2024","unstructured":"Duman H, Akda E, Gold Nanoparticles, Prospects F. Nanomaterials. 2024;14:1\u201356. https:\/\/doi.org\/10.3390\/nano14221805.","journal-title":"Nanomaterials"},{"key":"14030_CR64","doi-asserted-by":"publisher","first-page":"192","DOI":"10.2174\/1872211313666191024112137","volume":"13","author":"B Medeiros-Neves","year":"2019","unstructured":"Medeiros-Neves B, Nemitz MC, Silveira Fachel FN, Teixeira HF. Recent patents concerning the use of Nanotechnology-based delivery systems as skin penetration enhancers. Recent Pat Drug Deliv Formul. 2019;13:192\u2013202. https:\/\/doi.org\/10.2174\/1872211313666191024112137.","journal-title":"Recent Pat Drug Deliv Formul"},{"key":"14030_CR65","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.jpha.2023.06.001","volume":"13","author":"L Yao","year":"2023","unstructured":"Yao L, Bojic D, Liu M. Applications and safety of gold nanoparticles as therapeutic devices in clinical trials. J Pharm Anal. 2023;13:960\u20137. https:\/\/doi.org\/10.1016\/j.jpha.2023.06.001.","journal-title":"J Pharm Anal"},{"key":"14030_CR66","doi-asserted-by":"publisher","unstructured":"Andrade LM, Martins EMN, Versiani AF, Reis DS, da Fonseca FG, Souza IPD, et al. The physicochemical and biological characterization of a 24-month-stored nanocomplex based on gold nanoparticles conjugated with cetuximab demonstrated long-term stability, EGFR affinity and cancer cell death due to apoptosis. Mater Sci Eng C. 2020;107. https:\/\/doi.org\/10.1016\/j.msec.2019.110203.","DOI":"10.1016\/j.msec.2019.110203"},{"key":"14030_CR67","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1039\/df9511100055","volume":"11","author":"J Turkevich","year":"1951","unstructured":"Turkevich J, Stevenson Cooper P, Hillier J, A STUDY OF THE NUCLEATION, AND GROWTH PROCESSES IN THE SYNTHESIS OF COLLOIDAL GOLD. Discuss Faraday Soc. 1951;11:55\u201375.","journal-title":"Discuss Faraday Soc"},{"key":"14030_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnano.2025.1479464","volume":"7","author":"WS Mota","year":"2025","unstructured":"Mota WS, Severino P, Kadian V, Rao R, Zieli\u0144ska A, Silva AM, et al. Nanometrology: particle sizing and influence on the toxicological profile. Front Nanotechnol. 2025;7:1\u201319. https:\/\/doi.org\/10.3389\/fnano.2025.1479464.","journal-title":"Front Nanotechnol"},{"key":"14030_CR69","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1208\/s12249-014-0177-9","volume":"15","author":"R Paliwal","year":"2014","unstructured":"Paliwal R, Babu RJ, Palakurthi S. Nanomedicine Scale-up technologies: feasibilities and challenges. Ageing Int. 2014;15:1527\u201334. https:\/\/doi.org\/10.1208\/s12249-014-0177-9.","journal-title":"Ageing Int"},{"issue":"75","key":"14030_CR70","doi-asserted-by":"publisher","first-page":"48","DOI":"10.15587\/2706-5448.2024.299271","volume":"1 4","author":"V Malyshev","year":"2024","unstructured":"Malyshev V, Gab A, Kovalenko V, Pryshedko O, Shakhnin D. Estimation of global nanomedicine market: status, segment analysis, dynamics, competition and prospects. Technol Audit Prod Reserv. 2024;1 4(75):48\u201359. https:\/\/doi.org\/10.15587\/2706-5448.2024.299271.","journal-title":"Technol Audit Prod Reserv"},{"key":"14030_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep07490","volume":"7490","author":"Y Qian","year":"2014","unstructured":"Qian Y, Qiu M, Wu Q, Tian Y, Zhang Y, Gu N, et al. Enhanced cytotoxic activity of cetuximab in EGFR-positive lung cancer by conjugating with gold nanoparticles. Sci Rep. 2014;7490:1\u20138. https:\/\/doi.org\/10.1038\/srep07490.","journal-title":"Sci Rep"},{"key":"14030_CR72","doi-asserted-by":"publisher","first-page":"5659","DOI":"10.2147\/IJN.S140620","volume":"12","author":"C Yao","year":"2017","unstructured":"Yao C, H\u00fcttmann G. Important factors for cell-membrane permeabilization by gold nanoparticles activated by nanosecond-laser irradiation. Int J Nanomed. 2017;12:5659\u201372. https:\/\/doi.org\/10.2147\/IJN.S140620.","journal-title":"Int J Nanomed"},{"key":"14030_CR73","unstructured":"Faryaar H. Estimating markups using firm-level data: a comparative analysis. Toronto; 2025. Catalogue no. 11F0019M."},{"key":"14030_CR74","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1001\/jamaoto.2022.3340","volume":"148","author":"JR Miller","year":"2022","unstructured":"Miller JR, Frcik KD, Gourin CG. Hospital markup in head and neck cancer surgery in the US. JAMA Otolaryngol Head Neck Surg. 2022;148:1147\u201355. https:\/\/doi.org\/10.1001\/jamaoto.2022.3340.","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"14030_CR75","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.oor.2024.100645","volume":"11","author":"H Arantes","year":"2024","unstructured":"Arantes H, Chaves D, Morais R, Aparecida M, Braga MC, Pungartnik PC, et al. Head and neck squamous cell carcinoma epidemiology at diagnosis: A description of public and private health care systems in Brazil regarding tumor location, staging and risk factors. Oral Oncol Rep. 2024;11:11. https:\/\/doi.org\/10.1016\/j.oor.2024.100645. September 2022:.","journal-title":"Oral Oncol Rep"},{"key":"14030_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/23808993.2025.2505796","volume":"10","author":"JM Anaya","year":"2025","unstructured":"Anaya JM, Herr\u00e1n M, Pino LE. Challenges and opportunities for precision medicine in developing nations. Expert Rev Precis Med Drug Dev. 2025;10:1\u201315. https:\/\/doi.org\/10.1080\/23808993.2025.2505796.","journal-title":"Expert Rev Precis Med Drug Dev"},{"key":"14030_CR77","doi-asserted-by":"crossref","unstructured":"Souza A, Teixeira Vidal A, Gomes P. Avan\u00e7os Do Monitoramento Do Horizonte Tecnol\u00f3gico No Brasil. 1st ed. Brasilia: Editora MS; 2018.","DOI":"10.1016\/j.jval.2017.08.2437"},{"key":"14030_CR78","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.ygyno.2015.08.023","volume":"139","author":"G Larry Maxwell","year":"2015","unstructured":"Larry Maxwell G. The state of advocacy in cancer. Gynecol Oncol. 2015;139:573\u20139. https:\/\/doi.org\/10.1016\/j.ygyno.2015.08.023.","journal-title":"Gynecol Oncol"},{"key":"14030_CR79","doi-asserted-by":"publisher","unstructured":"Brand\u00e3o SMG, La Rocca H-PB, de Lima ACP, Bocchi EA. A review of cost-effectiveness analysis from theory to clinical practice. Med (Baltim). 2023;42. https:\/\/doi.org\/10.1097\/MD.0000000000035614. May:102:42.","DOI":"10.1097\/MD.0000000000035614"},{"key":"14030_CR80","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jceh.2019.11.001","volume":"10","author":"N Gupta","year":"2020","unstructured":"Gupta N, Verma R, Dhiman RK, Rajsekhar K, Prinja S. Cost-Effectiveness analysis and decision modelling: A tutorial for clinicians. J Clin Exp Hepatol. 2020;10:177\u201384. https:\/\/doi.org\/10.1016\/j.jceh.2019.11.001.","journal-title":"J Clin Exp Hepatol"},{"key":"14030_CR81","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1080\/15598608.2012.695571","volume":"6","author":"H Bang","year":"2012","unstructured":"Bang H, Zhao H. Median-Based incremental Cost-Effectiveness ratio (ICER). J Stat Theory Pr. 2012;6:428\u201342. https:\/\/doi.org\/10.1080\/15598608.2012.695571.","journal-title":"J Stat Theory Pr"},{"key":"14030_CR82","doi-asserted-by":"publisher","unstructured":"Hillegonda Maria Dutilh Novaes PC de S. Health technology assessment (HTA) organizations: dimensions of the institutional and political framework. Cad Saude Publica. 2016;1\u201314. https:\/\/doi.org\/10.1590\/0102-311X00022315.","DOI":"10.1590\/0102-311X00022315"},{"key":"14030_CR83","unstructured":"Saude. BM da SS de A a. Protocolos Clinicos e Diretrizes Terapeuticas_Volume II. 2nd ed. Brasilia: Editora MS; 2013."},{"key":"14030_CR84","unstructured":"CONITEC. EuroScan International Network, a toolkit for the identification and assessment of new and emerging health technologies. 2014."}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-026-14030-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-026-14030-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-026-14030-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T17:09:34Z","timestamp":1771434574000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12913-026-14030-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":84,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["14030"],"URL":"https:\/\/doi.org\/10.1186\/s12913-026-14030-2","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"assertion":[{"value":"2 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Permission to use the secondary database was added in the ethics approval section.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"251"}}